首页> 美国卫生研究院文献>British Medical Journal >Elective End-to-side Portacaval Shunt: Results in 64 Cases
【2h】

Elective End-to-side Portacaval Shunt: Results in 64 Cases

机译:端到端选择性门腔分流术:64例结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In a series of 64 cases of elective end-to-side portacaval shunts performed for liver disease the success rate—in that the patient survived with a patent shunt, free of subsequent haemorrhage and severe encephalopathy—was 48%.The early postoperative death rate was 12·5% and the five-year survival 65%. Bleeding from oesophagogastric varices after blockage of the shunt was responsible for at least half of the early postoperative deaths, and most late deaths were due to liver failure. A decreased chance of late survival was associated with age over 40 years, active chronic hepatitis, and with a preoperative history of hepatocellular jaundice.Shunt blockage occurred in 16% of patients, and all bled again from oesophagogastric varices. Shunt block is more likely if the portal vein is calcified or thrombosed, and may be more likely if the portal vein diameter, as shown by splenic venography, is 1·5 cm or less.In survivors with a patent shunt the most serious late complication was chronic, severe portal-systemic encephalopathy, which occurred in 38%. Severe encephalopathy was associated with age over 40 years, a preoperative history of any degree of encephalopathy, diabetes mellitus, and with continued drinking in the alcoholic. Most patients who had portal-systemic encephalopathy in the first year postoperatively developed chronic disabling encephalopathy.A preoperative history of transient mild or moderate ascites did not seem adversely to influence the outcome.
机译:在一系列针对肝病进行的选择性端到端门腔分流术的64例病例中,成功的患者获专利分流术,无随后的出血和严重脑病,成功率为48%。术后早期死亡率是12·5%,五年生存率是65%。分流器阻塞后食管胃底静脉曲张出血至少占术后早期死亡的一半,而大多数晚期死亡是由于肝衰竭引起的。晚期存活率降低与年龄超过40岁,活动性慢性肝炎以及术前肝细胞性黄疸有关.16%的患者发生分流阻塞,并再次因食管胃底静脉曲张而出血。如果门静脉钙化或血栓形成,则更可能发生分流阻塞,如果脾静脉造影显示门静脉直径为1·5 cm或更小,则更可能发生分流。在有专利分流术的幸存者中,最严重的晚期并发症是为慢性,严重的门静脉系统性脑病,发生率为38%。严重的脑病与40岁以上的年龄,任何程度的脑病,糖尿病和术前持续饮酒有关。术后第一年多数患有门静脉系统性脑病的患者发展为慢性致残性脑病,术前短暂或中度腹水病史似乎对预后没有不利影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号